A potential role for PDLIM2 in modulating tumour immunity and chemotherapy has been proposed in lung cancer, where in mouse models PDLIM2 ectopic expression can enhance antigen presentation and T cell activity, while its suppression by reactive oxygen species promotes recruitment and pro-tumourigenic activity of alveolar macrophages (17, 49). This evidence concerns the gene PDLIM2 and lung carcinoma.